Search for: "Bayer Laboratories, Inc." Results 61 - 80 of 161
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jun 2011, 5:00 am by Bexis
Bayer Cropscience, Inc., ___ S.W.3d ___, 2011 WL 2184317, at *10-13 (Tenn. [read post]
22 Jun 2011, 4:09 am by Marie Louise
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods:  Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche (IPKat) (IPKat) US: Manager’s Amendment (and… [read post]
14 Jun 2011, 8:51 pm
Bayer Corporation, previously known as Berlex Laboratories, Inc. and Berlex, Inc., manufactures these birth control pills. [read post]
2 Jun 2011, 12:46 pm by Bexis
Bayer Corp., ___ F.3d ___, 2011 WL 1938428, at *5-6 (7th Cir. [read post]
19 May 2011, 9:12 pm
In Abbott Laboratories v. [read post]
6 Apr 2011, 12:18 am by Marie Louise
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive… [read post]
7 Mar 2011, 7:44 am by Kali Borkoski
Bayer AGDocket: 10-762Issue(s): Whether, absent patent fraud or sham litigation, a brand drug maker's substantial payment to a competing generic drug maker to forgo judicial testing of the patent and restrict entry is per se lawful under the Sherman Act.Certiorari stage documents:Opinion below (2d Cir.)Petition for certiorariBrief in opposition of Barr Laboratories et al.Brief in opposition of Bayer AG et al.Petitioners' replyAmicus brief of the American… [read post]
16 Feb 2011, 12:41 pm by Tom Lamb
This current number of YAZ / Yasmin / Ocella lawsuits filed against the Bayer defendants -- typically some combination of: Bayer Corporation; Bayer Healthcare Pharmaceuticals, Inc.; Bayer Healthcare, LLC; and, Berlex Laboratories International, Inc. -- is remarkable if you consider: (1) Bayer said there were 1,100 lawsuits filed as of mid-February 2010 (one year ago); and, (2) Bayer said there were 129 YAZ / Yasmin /… [read post]
19 Jan 2011, 2:44 pm by Phil
The case goes back to $398 million that Bayer allegedly paid Watson Pharmaceuticals Inc., Barr Laboratories Inc. and others supposedly in exchange for the companies not marketing lower-cost generic versions of the antibiotic Cipro. [read post]
18 Jan 2011, 3:10 am by Scott A. McKeown
See Merck & Co., 482 F.3d at 1319; see also Bayer AG, 298 F.3d at 1381. [read post]
29 Dec 2010, 12:54 pm by Bexis
Bayer, 09-1205) in the Supreme Court, might that case now be moot? [read post]
8 Dec 2010, 2:20 am by Marie Louise
Highlights this week included: India: Supreme Court dismisses Bayer’ petition in patent linkage matter (Generic Pharmaceuticals and IP) (Spicy IP) (GenericsWeb) (SiNApSE) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
6 Dec 2010, 2:36 am by Kelly
Johnson & Johnson (Kluwer) EWHC (Pat) finds no infringement of coronary stent patents: Abbott Laboratories Limited v. [read post]
24 Nov 2010, 12:37 am by Kelly
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an… [read post]
11 Nov 2010, 12:54 pm by Bexis
Syntex Laboratories, Inc., 444 So.2d 203, 205-06 (La. [read post]
9 Sep 2010, 4:01 pm by Lawrence B. Ebert
"Reuters had written:On April 29, a three-judge panel in New York upheld a lower court's ruling dismissing objections to Bayer AG paying Teva Pharmaceutical Industries Inc's Barr Laboratories to prevent it from bringing to market a version of the anthrax drug Cipro.But the panel invited further review by the full nine-judge panel of the U.S. [read post]